Nom du produit:bicyclo[1.1.1]pentane-1,3-dicarboxylic acid

IUPAC Name:bicyclo[1.1.1]pentane-1,3-dicarboxylic acid

CAS:56842-95-6
Formule moléculaire:C7H8O4
Pureté:98%+
Numéro de catalogue:CM103630
Poids moléculaire:156.14

Unité d'emballage Stock disponible Prix($) Quantité
CM103630-500g in stock ȃƿŹȃ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:56842-95-6
Formule moléculaire:C7H8O4
Point de fusion:-
Code SMILES:OC(=O)C12CC(C1)(C2)C(O)=O
Densité:
Numéro de catalogue:CM103630
Poids moléculaire:156.14
Point d'ébullition:
N° Mdl:MFCD20621127
Stockage:

Category Infos

Bridged Compounds
Bridged ring compound refers to any two rings in the compound, which share two non-directly connected carbon atoms, and are classified into bicyclic hydrocarbons, tricyclic hydrocarbons, tetracyclic hydrocarbons, etc. Carbon atoms used in two or more rings are bridgehead carbon atoms, and the bond connecting the bridgehead carbon atoms is called a bridge. Bridged ring compounds are a class of organic compounds that are widely present in nature and usually have important physiological activities, such as the famous anticancer drug paclitaxel and antimalarial drug artemisinin.
bridged compounds,bridged bicyclic compounds
Buy low price, high quality bridged compounds and bridged bicyclic compounds,choose our products,Chemenu is the leading factory & company. Warmly welcome new and old customers to visit and patronize!
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

Column Infos